Business Context and Reporting Period
This Form 8-K is a current report filed by SELLAS Life Sciences Group, Inc. on July 9, 2019. The company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market under the symbol "SLS". The report addresses "Other Events" under Item 8.01.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding share count and does not contain financial statements.
Material Changes
The primary disclosure in this filing is the update of the company's outstanding share count. As of July 9, 2019, SELLAS Life Sciences Group, Inc. had 127,690,919 shares of common stock outstanding. No other material changes to operations or financial condition are detailed in this specific report.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The report is limited to the disclosure of the outstanding share count.
Investor Verification Checklist
- Verify the total outstanding common stock count of 127,690,919 shares as of July 9, 2019.
- Confirm the trading symbol "SLS" on The Nasdaq Capital Market.
- Note that this filing does not contain financial performance data; refer to the most recent 10-Q or 10-K for financial metrics.